Invega

NDA 22043, held by Janssen LP. Paliperidone.

As of Nov 14, 2026, NDA 22043 (Invega), held by Janssen LP, was first approved by FDA on Apr 27, 2007, with 0 approved supplements and 0 published complete response letters.

• First approved: Apr 27, 2007
• Review: Standard
• Supplements approved: 0
• Complete response letters: 0

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters